K070822

Substantially Equivalent

ARCHITECT SIROLIMUS ASSAY

Applicant: Fujirebio Diagnostics,Inc.
Product code: NRP
Advisory panel: Clinical Toxicology
Date received: 2007-03-26
Decision date: 2007-09-28
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Malvern, PA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.